Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Kymera Therapeutics Inc (NASDAQ: KYMR) closed at $30.68 up 1.69% from its previous closing price of $30.17. In other words, the price has increased by $1.69 from its previous closing price. On the day, 0.61 million shares were traded.
Ratios:
For a deeper understanding of Kymera Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.53 and its Current Ratio is at 7.53. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on December 10, 2024, initiated with a Buy rating and assigned the stock a target price of $60.
On December 06, 2024, BMO Capital Markets started tracking the stock assigning a Market Perform rating and target price of $55.
Wells Fargo Upgraded its Equal Weight to Overweight on December 02, 2024, while the target price for the stock was maintained at $57.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 03 ’25 when Chiniara Ellen sold 2,241 shares for $30.45 per share. The transaction valued at 68,239 led to the insider holds 80,085 shares of the business.
Chadwick Jeremy G sold 1,383 shares of KYMR for $42,113 on Mar 03 ’25. The Chief Operating Officer now owns 67,800 shares after completing the transaction at $30.45 per share. On Mar 03 ’25, another insider, Jacobs Bruce N., who serves as the Chief Financial Officer of the company, sold 7,035 shares for $30.45 each. As a result, the insider received 214,219 and left with 201,886 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 42.33 while its Price-to-Book (P/B) ratio in mrq is 2.38.
Stock Price History:
Over the past 52 weeks, KYMR has reached a high of $53.27, while it has fallen to a 52-week low of $29.16. The 50-Day Moving Average of the stock is -20.59%, while the 200-Day Moving Average is calculated to be -26.18%.
Shares Statistics:
A total of 64.89M shares are outstanding, with a floating share count of 54.06M. Insiders hold about 16.76% of the company’s shares, while institutions hold 95.09% stake in the company.
